This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Lapatinib

From Proteopedia

Revision as of 08:38, 6 December 2010 by David Canner (Talk | contribs)
Jump to: navigation, search

Pharmacokinetics

Tyrosine Kinase Inhibitor Pharmacokinetics [1][2][3][4][5]
Parameter Sunitinib (Sutent) Sorafenib (Nexavar)
Tmax (hr) 8 8.3
Cmax (ng/ml) 24.6 460
Bioavailability (%) Sunitinib (Sutent) 29-49
Protein Binding (%) 95 99
T1/2 (hr) 83 29
AUC (ng/ml/hr) 1921 11040
IC50 (nM) Sunitinib (Sutent) Sorafenib (Nexavar)
Dosage (mg) 50 50
Metabolism Hepatic (CYP3A4) Hepatic (CYP3A4)

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Joel L. Sussman

Retrieved from "http://52.214.119.220/wiki/index.php/Lapatinib"
Personal tools